<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator activated receptor-gamma is an important factor in adipocyte differentiation and energy metabolism and is thus a candidate gene for <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We therefore assessed the associations between the most common variant of the PPAR-gamma, the Pro12Ala (P12A) substitution in the PPAR-gamma 2 gene, with BMI, blood pressure, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA1c, total cholesterol, <z:chebi fb="15" ids="39026">LDL</z:chebi> and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and plasma <z:chebi fb="0" ids="17855">triglyceride</z:chebi> in 183 treatment-na√Øve patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2D) </plain></SENT>
<SENT sid="2" pm="."><plain>The P12A allele associated with lower fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> but had no influence on HbA1c or BMI </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mp ids='MP_0001261'>obese</z:mp> patients (BMI &gt; 29 kg/m2), the P12A substitution associated with elevated total and non-<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> levels </plain></SENT>
</text></document>